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Abstract
BACKGROUND—Essential tremor (ET) is associated with both functional disability and
depression. Each could contribute to a poor sense of well-being and low morale. We hypothesized
that morale would be lower in ET cases than controls.
METHODS—Using a population-based, cross-sectional design, morale was assessed in 187 ET
cases and 561 matched controls living in three communities in central Spain using the Philadelphia
Geriatric Center Morale Scale (PGCMS)(range = 0 [low morale]–17), which included three
dimensions of psychological well-being: agitation, lonely dissatisfaction, and attitude toward own
aging.
RESULTS—The PGCMS score was lower in ET cases than controls (9.41 ± 3.21 vs. 10.39 ± 2.92,
p < 0.001), as were the Agitation subscore (3.17 ± 1.71 vs. 3.78 ± 1.67, p < 0.001) and Lonely
Dissatisfaction subscore (3.75 ± 1.34 vs. 4.02 ± 1.24, p < 0.05). Nearly one-half of the ET cases were
classified as having low morale compared with only one-third of controls (p = 0.006). In a linear
regression analysis adjusting for demographic factors and multiple comorbid conditions, ET cases
had a lower log PGCMS score than controls (p < 0.001). Exclusion of participants on antidepressant
medication did not change the results.
CONCLUSIONS—Our results indicate that morale is significantly lower in community-dwelling
ET cases than in matched controls. This lower morale could in part be a proxy for mild, untreated
depression. It therefore seems important to detect and then possibly treat this problem to improve
the psychological well-being of patients with this disease.
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Introduction
Essential tremor (ET) is one of the most common adult-onset neurological diseases.1,2 The
tremor is often progressive,3 resulting in difficulty performing basic daily activities.4,5 Even
among community-dwelling cases, who have milder tremor than clinic-derived cases, three-
fourths report disability, with most experiencing this disability in multiple functional domains.
5 Hence, it is apparent that tremor often brings with it changes in the patients’ life situation.
In addition to functional difficulties, ET is associated with depression;6 both could contribute
to low morale and a poor sense of well-being.
Morale may be defined as the level of individual psychological well-being based on such factors
as a sense of purpose and confidence in the future. It is important to assess patient morale.
First, it provides a patient-centered measure of well-being. Second, it can provide insights into
patient motivations for pursuing or declining a range of medical and surgical treatment options.
Finally, poor psychological well-being is a problem that is worthwhile focusing on in its own
right, particularly as a growing elderly population attempts to age successfully.
There are few data on morale in ET. We had the opportunity to study morale in three
communities in central Spain. Comparing three samples of ET cases to matched controls, we
hypothesized that morale would be lower in ET cases. Moreover, the study considered
numerous confounding comorbidities to distinguish their impact on morale from that of ET.
Methods
Study Population
Data were derived from the Neurological Disorders in Central Spain (NEDICES) study, a
longitudinal, population-based survey of major age-associated conditions of the elderly.7,8
The study sample, from three communities in central Spain (Las Margaritas, Lista, and
Arevalo), consisted of 6,395 individuals. A detailed account of the study population, sampling
methods, and assessments has been published.7–11 All procedures were approved by the
University’s ethical standards committee on human experimentation. Written (signed)
informed consent was obtained from all participants upon enrollment.
Baseline Evaluation (1994 to 1995)
At baseline, subjects were interviewed using a structured screening questionnaire that assessed
demographic factors, medical conditions (each assessed by self-report, Table 1) and lifestyle
variables.7–11 The questionnaire included one screening question for ET,10,11 with high
negative predictive value (183 true negatives and 0 false negatives).11 Persons who screened
positive for ET underwent a neurological examination, which included a general neurological
examination, the motor portion of the Unified Parkinson’s Disease Rating Scale (UPDRS),
12 and three manual tasks to assess postural and kinetic tremors. For subjects who could not
be examined, medical records and death certificates were reviewed.
Subjects were diagnosed with ET if they had an action tremor of the head, limbs, or voice
without any other recognizable cause. Second, the tremor had to be of gradual onset (i.e., slow
and progressive) and (1) present for at least 1 year or (2) accompanied by a family history of
the same disorder (at least one reportedly-affected first-degree relative). Third, on an
Archimedes spiral, tremor severity had to be moderate or greater (rating ! 2 according to the
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Washington Heights-Inwood Genetic Study of ET Rating Scale).13 Prior community-based
investigations in New York demonstrated that while the majority of ET cases have tremor of
this severity during spiral drawing, only 2.3% of normal elderly control subjects do, indicating
that these spiral ratings are useful in distinguishing individuals with ET from those with normal
(enhanced physiological) tremor.14 Subjects with tremor related to alcohol withdrawal,
hyperthyroidism, anxiety, Parkinson disease (PD), antidopaminergic drug intake, lithium
therapy, or other known causes of tremor, were not considered to have ET. There were 256
(4.8%) prevalent ET cases.10 PD and other forms of parkinsonism were diagnosed when at
least two cardinal signs (resting tremor, rigidity, bradykinesia, and impaired postural reflexes)
were present on UPDRS.15 The diagnosis of dementia was madeby consensus of two
neurologists, who applied the Diagnostic and StatisticalManual of Mental Disorders (DSM)–
IV criteria, and requiredevidence of cognitive deficit (neuropsychological testbattery, clinical
mental status examination) and impairment in social or occupationalfunction.16
Follow-Up Evaluation (1997 to 1998) and Assessment of Morale
During the second (i.e., follow-up) evaluation (1997 to 1998), the same methods (screening
and examination) were used for the diagnosis of ET, PD, parkinsonism and dementia. Eighty-
three incident ET cases were identified.11
For subjects who were examined, a subjective quality of life questionnaire was administered
by psychologists, social workers, student nurses and general physicians, all of whom had been
trained by a senior clinical investigator with expertise in health sciences research (see
acknowledgements, J. R-N.). This questionnaire, the Philadelphia Geriatric Center Morale
Scale (PGCMS),17 was designed to provide a measure of morale or psychological well-being
in social gerontological studies.17–19 As such, it was selected for NEDICES, in which a broad
array of neurological disorders of the elderly was assessed.. The scale measures three
consistently reproducible factors, which capture different dimensions of psychological well-
being: agitation, lonely dissatisfaction, and attitude toward own aging. The agitation factor is
comprised of 6 questions that assess anxiety and dysphoria, the lonely dissatisfaction factor is
comprised of 6 questions that assess the acceptance or dissatisfaction with the social
interactions the subject experiences, and the final factor is comprised of 5 questions that assess
the subject’s attitude towards the aging process. Each of the 17 questions is scored so that the
value 0 indicates low morale and the value 1 indicates high morale; the total score ranges from
0–17. It has been suggested that scores of 13 to 17 are consistent with high morale, scores of
10 to 12 with a middle range, and scores " 9 with lower morale.19 The scale, which is short
and easy to administer, has demonstrated high inter-rater reliability and internal consistency
and it has been used in a variety of gerontological studies in a number of countries17–19
(including Spain),20,21 indicating that there is cross-cultural comparability.
Final Sample
There were 3,816 participants evaluated at follow-up. We excluded 146 participants with PD
or other forms of parkinsonism as our intentionwas to assess whether ET was associatedwith
lower morale in a cohort without other competing movement disorders. Fifteen subjects were
excluded due to insufficient medical information. Of the remaining 3,655 participants, there
were 273 ET cases and 3,382 participants without ET (controls). We excluded an additional
1,313 participants (96 with ET and 1,217 controls) who either: (1) were not examined and
therefore had no data on morale (N = 780) or (2) had incomplete data (N = 533). This left an
eligible sample of 177 ET cases and 2,165 controls for these analyses. The 177 ET cases were
frequency-matched to 531 controls (1:3 ratio) based on age and gender. We compared the final
177 ET cases to the base sample of 273 ET cases and they were similar in terms of age (76.6
± 6.2 vs. 77.0 ± 6.6 years, t = 0.66, p = 0.51), gender (108 [61.0%] vs. 165 [60.4%] women,
chi-square [#2] = 0.02, p = 0.90), and education (33 [18.6%] vs. 58 [21.2%] illiterate, #2 =
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0.45, p = 0.50). Also, the 531 matched controls were compared to the base sample of 3,382
controls and they were similar in terms of age (76.1 ± 6.2 vs. 75.7 ± 6.3 years, t = 1.26, p =
0.21), gender (317 [59.7%] vs. 1,984 [58.7%] women, #2 = 0.20, p = 0.65), and education (59
[11.1%] vs. 403 [11.9%] illiterate, #2 = 0.29, p = 0.59).
Data analyses
Statistical analyses were performed in SPSS Version 15.0 (SPSS, Inc., Chicago, IL).
Demographic and clinical characteristics of ET cases and controls were compared using two-
sided Student’s t tests, analysis of variance (ANOVA), and #2 tests. PGCMS score and
subscores were not normally distributed and, therefore, non-parametric tests (Mann Whitney
and Spearman’s correlation coefficients) were used to assess associations between PGCMS
scores and demographic factors and comorbid conditions. A Mann Whitney test was used to
compare PGCMS scores in ET cases vs. controls. PGCMS scores were stratified into low
morale (" 9), intermediate morale (10–12) and high morale (13–17).19 We began with an
unadjusted linear regression analysis in which total log-transformed PGCMS score was the
dependent variable and diagnosis (ET vs. control) was the independent variable. Covariates
were included in adjusted models when they were associated with either the dependent or
independent variable in univariate analyses or when there was strong prior biological support
for an association.
Results
The 177 ET cases and 531 frequency-matched controls were similar in terms of age, gender,
smoking, and numerous medical comorbidities (e.g., diabetes, hypertension, heart disease,
Table 1). The mean duration of ET was 10.0 ± 11.7 years. Forty-five (25.4%) ET cases had a
family history of ET and 5 (2.8%) were taking a medication to treat ET.
In controls, lower PGCMS score was not significantly correlated with higher age (Spearman’s
r = $0.05, p = 0.28); lower PGCMS score (i.e., lower morale) was found in women, illiterate
participants, non-smokers, participants with arthritis, and marginally in participants with
hypertension (Table 2).
The PGCMS score was lower in ET cases than controls, as were the Agitation subscore and
Lonely Dissatisfaction subscore (Table 3). The PGCMS score was lower in cases than controls
in each of the three Spanish communities; this difference reached significance in two of the
three communities (Table 3). PGCMS scores were stratified into categories (low morale [" 9],
intermediate morale [10–12] and high morale [13–17]); nearly one-half of the ET cases were
classified as having low morale compared with only one-third of controls (82 [46.3%] vs. 182
[34.3%], #2 = 10.10, p = 0.006).
In an unadjusted linear regression analysis, ET cases had a lower the log PGCMS score than
did controls (beta = $0.055, p < 0.001). In a linear regression analysis that adjusted for age,
gender, education, ever cigarette smoker, hypertension, and arthritis, the results were similar
(beta = $0.050, p < 0.001). In a linear regression analyses that further adjusted for the above
variables (age, gender, education, ever cigarette smoker, hypertension, arthritis) as well as
additional comorbid medical conditions (diabetes, heart disease, chronic obstructive
pulmonary disease, hip fracture, hearing difficulty, visual problems), the results were similar
(beta = $0.052, p < 0.001). Exclusion of 16 (9.0%) ET cases and 27 (5.1%) controls with DSM-
IV-diagnosed dementia did not change the results (for fully adjusted model, beta = $0.052, p
< 0.001). Further exclusion of 10 (6.2%) ET cases and 19 (3.8%) controls who were taking an
antidepressant medication did not change the results (for fully adjusted model, beta = $0.046,
p = 0.002).
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The PGCMS score did not differ in ET cases who had vs. did not have a family history of ET,
or in ET cases who did vs. did not take a medication to treat ET. The PGCMS score was not
correlated with tremor duration (Spearman’s r = 0.04, p = 0.59).
The PGCMS score was 8.08 ± 3.90 among 13 ET cases taking antidepressant medication vs.
9.51 ± 3.13 among 164 ET cases not taking these medications (Mann Whitney z = 1.22, p =
0.22). Among controls, these scores were 8.74 ± 3.18 vs. 10.46 ± 2.90, Mann Whitney z = 2.30,
p = 0.02.
Data on tremor severity were not available; however, a number of the ET cases had not been
diagnosed with ET prior to this study. We used this variable (new ET diagnosis vs. prior ET
diagnosis) as a proxy for tremor severity; in an analysis in which we compared 37 ET cases
with new vs. 140 ET cases with prior ET diagnoses, the PGCMS scores did not differ (8.81 ±
2.97 vs. 9.56 ± 3.26, Mann Whitney z = 1.36, p = 0.17).
While all ET cases had a tremor of duration of 1 or more years, in 47 (26.6%), it was < 3 years.
When we excluded these 47, the PGCMS score in the remaining 130 ET cases was 9.59 ± 3.25,
which was lower than that of controls (Mann Whitney z = 2.54, p = 0.01).
Discussion
We demonstrated that morale was lower in community-dwelling ET cases than in matched
counterparts without ET. Furthermore, the lower morale was related to ET as we controlled
for a variety of confounding comorbid medical conditions. Even after excluding study
participants who were taking antidepressant medications, morale was lower in ET cases than
controls.
This lower morale could in part be a proxy for mild, untreated depression. It would therefore
seem important to detect and possibly treat this problem to improve the psychological well-
being of patients with this disease. We compared ET cases who were taking antidepressant to
ET cases who were not taking these medications. Interestingly, the morale was lower among
the ET cases who were taking antidepressants. Patients who take antidepressants often have
only partially treated depression, which may explain these results.
Our results also suggest that mood disturbance is not entirely responsible for the observed
lower morale in ET. Morale scores were lower in ET cases than in controls even after stratifying
by antidepressant use (i.e., morale scores trended to be lower in ET cases taking antidepressants
vs. controls taking antidepressants, and morale scores also trended to be lower in ET cases who
were not taking antidepressants vs. controls who were not taking antidepressants), which
suggests that the lower morale may not be completely due to an underlying mood disturbance.
Morale is one aspect of quality of life, which can include physical function, pain, and general
health as well as energy, social function and mental health. There are limited data on health-
related quality of life in ET. These, studies, however, have been for the most part in highly-
selected ET patients with severe medically-refractory tremor who were undergoing tremor
surgery.22, 23 Apart from these surgical series, there have been two studies of quality of life
in ET.24, 25 In one of these studies,24 clinic patients with ET were compared to a group of
historical controls and quality of life was lower in the clinic patients, with both physical and
mental domains seemingly affected by ET. There has been only one prior community-based
study of quality of life in ET; in that study, a small sample of 34 ET cases and 34 matched
controls were compared using the Rand-SF36, a different instrument than the one we used in
this study.25 The investigators demonstrated poorer overall quality of life in ET cases than
controls, but cases had more co-morbidity (e.g., diabetes, osteoarthritis) than controls and these
potential confounders were not adjusted for in the analyses.25 Scores were slightly lower in
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ET cases in the social function and emotional well-being domains, yet the sample size limited
the power of these analyses to detect case-control differences in these domains.25
In previous studies, it has been suggested that PGCMS scores " 9 are consistent with low
morale.19 In the current sample, nearly one-half of the ET cases were classified as having low
morale compared with only one-third of controls, indicating that low morale is a common
feature in ET cases. Moreover, the current cases were largely un-medicated, community-
dwelling ET cases; one would expect even lower morale among cases ascertained from
treatment centers.
Of the three PGCMS subscores, the agitation and lonely dissatisfaction subscores were the
most affected by ET. Despite the fact that ET is often viewed solely as a disorder of aging, ET
cases generally expressed only mild, non-significant concerns about their aging.
This study had limitations. We used a geriatric questionnaire aimed at assessing morale rather
than an ET-specific quality of life questionnaire. Recently, a 30-item ET-specific quality of
life questionnaire was developed;26 it post-dated our study. This study also had considerable
strengths. We sampled ET cases from communities, thereby avoiding the types of biases that
occur when sampling medical or surgical patients and who are likely to be self-selected for
lower morale or a poorer sense of well-being. The effect of ET on morale that we estimated
should be viewed as a conservative estimate; presumably, clinic-based studies would find even
greater effects. The study design also allowed us to assess morale in parallel in three separate
Spanish communities. Finally, we were able to consider a variety of confounding comorbidities
and adjust for these in our analyses in order to distinguish the impact of ET from that of other
medical conditions.
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Table 1
Demographic and clinical characteristics of ET cases and controls
ET Cases (N = 177) Controls (N = 531)
Age in years 76.6 ± 6.2 76.1 ± 6.2
Female gender 108 (61.0%) 317 (59.7%)
Education
!Illiterate 33 (18.6%) 59 (11.1%)
!Can read and write 70 (39.5%) 221 (41.6%)
!Primary studies 54 (30.5%) 183 (34.5%)
!!Secondary studies 20 (11.3%) 68 (12.8%)
Ever cigarette smoker 55 (31.1%) 192 (36.2%)
Diabetes 34 (19.4%) 98 (18.7%)
Hypertension 87 (49.7%) 267 (50.6%)
Heart disease 23 (13.1%) 54 (10.2%)
Chronic obstructive pulmonary disease 45 (25.4%) 120 (22.6%)
Arthritis 128 (72.3%) 372 (70.1%)
Hip fracture 12 (6.8%) 33 (6.2%)
Hearing difficulty 82 (46.3%) 211 (39.7%)
Visual problems 131 (74.0%) 416 (78.3%)
All p > 0.05 comparing ET cases to controls (t tests, #2 tests, ANOVA).
In some cells, there are missing data so that the total number of participants does not add up to 177 for ET cases or 531 for controls.
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Table 2
PGCMS score by demographic factors and comorbid conditions (in controls)
Condition present Condition absent
Female gender 10.03 ± 3.08*** 10.93 ± 2.59
Education = illiterate 9.36 ± 3.21** 10.52 ± 2.86
Ever cigarette smoker 10.89 ± 2.42** 10.11 ± 3.14
Diabetes 10.04 ± 3.07 10.47 ± 2.89
Hypertension 10.15 ± 3.10* 10.65 ± 2.70
Heart disease 9.81 ± 3.29 10.44 ± 2.87
Chronic obstructive pulmonary disease 10.01 ± 3.19 10.51 ± 2.84
Arthritis 9.98 ± 2.97**** 11.37 ± 2.58
Hip fracture 9.91 ± 3.44 10.43 ± 2.89
Hearing difficulty 10.33 ± 2.89 10.43 ± 2.95








p < 0.001 comparing condition present to condition absent (Mann Whitney test).
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Table 3
PGCMS scores in ET cases and controls
ET Cases (N = 177) Controls (N = 531)
PGCMS Score 9.41 ± 3.21 (10)*** 10.39 ± 2.92 (11)
!Lista (N = 218) 9.21 ± 3.29** 10.69 ± 2.95
!Arévalo (N = 282) 9.64 ± 3.27 10.06 ± 2.83
!Las Margaritas (N = 208) 9.30 ± 3.12** 10.54 ± 3.01
Agitation Subscore 3.17 ± 1.71 (3)*** 3.78 ± 1.67 (4)
!Little things bother me more this year 0.51 ± 0.50* 0.60 ± 0.49
!I sometimes worry so much that I can’t sleep 0.45 ± 0.50* 0.54 ± 0.50
!I am afraid of a lot of things 0.67 ± 0.47*** 0.81 ± 0.39
!I get mad more than I used to 0.59 ± 0.49* 0.68 ± 0.47
!I take things hard 0.41 ± 0.49** 0.53 ± 0.50
!I get upset easily 0.54 ± 0.50 0.62 ± 0.49
Lonely Dissatisfaction Subscore 3.75 ± 1.34 (4)* 4.02 ± 1.24 (4)
!I sometimes feel that life isn’t worth living 0.75 ± 0.44** 0.84 ± 0.37
!I have a lot to be sad about 0.56 ± 0.50 0.62 ± 0.49
!Life is hard for me much of the time 0.63 ± 0.49** 0.76 ± 0.43
!I am satisfied with my life today 0.70 ± 0.46* 0.78 ± 0.42
!I feel lonely 0.29 ± 0.46 0.24 ± 0.43
!I see enough of my friend and relatives 0.82 ± 0.38 0.79 ± 0.41
Attitude Toward Own Aging Subscore 2.49 ± 1.18 (2) 2.60 ± 1.10 (3)
!Things keep getting worse as I get older 0.27 ± 0.45 0.34 ± 0.48
!I have as much pep as I had last year 0.44 ± 0.50* 0.55 ± 0.50
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ET Cases (N = 177) Controls (N = 531)
!As I get older I am less useful 0.63 ± 0.48** 0.51 ± 0.50
!As I get older things are better than I thought they would be 0.67 ± 0.47 0.72 ± 0.45
!I am as happy now as when I was younger 0.47 ± 0.50 0.48 ± 0.50






p < 0.001 comparing ET cases to controls (Mann Whitney test).
Each of the 17 questions is scored so that the value 0 indicates low morale and the value 1 indicates high morale. Hence, lower scores indicate lower
morale and higher scores indicate higher morale.
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